ClinicalTrials.Veeva

Menu

Observation of the Comfort and Efficacy of CO2 Laser Combined With Cryo 6 for Burn or Linear Scars.

K

Kaiyang Lv, MD-PhD

Status

Enrolling

Conditions

Scar; Previous Cesarean Section
Cryotherapy Effect
Burn Scar

Treatments

Device: Cold-air cooling

Study type

Interventional

Funder types

Other

Identifiers

NCT05555602
XH-21-010

Details and patient eligibility

About

To investigate the effect of 10,600 nm CO2 laser combined with Zimmer Cryo 6 forced cold air device on the comfort and efficacy of patients with burn scars or post-operative linear scars, and to provide a safer, more effective and more satisfactory program for clinical treatment of burn scars or post-operative linear scars.

Full description

Objective: To investigate the effect of 10,600 nm CO2 laser combined with the cold-air cooling device Zimmer Cryo 6 on the comfort and efficacy of patients with burn scars or post-operative linear scars, and to provide a safer, more effective and more satisfactory program for clinical treatment of burn scars or post-operative linear scars.

Secondary objective: To investigate the adverse effects of the cold-air cooling device Zimmer Cryo 6 in combination with the 10,600 nm CO2 fractional laser treatment for patients with burn scars or post-operative linear scars.

Enrollment

40 estimated patients

Sex

All

Ages

14 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Age 14-60 years;
  2. The patient agreed to participate in the experiment and signed the informed consent by himself/herself or his/her legal representative;
  3. The clinical diagnosis was burn scar or post-operative linear scar, and the total area was more than 5 cm2.
  4. No other treatment such as laser or chemical exfoliation was performed on the lesion within the recent half year.
  5. Skin lesions were free of bleeding, ulceration, infection and other conditions affecting the visual field of laser treatment.

Exclusion criteria

  1. Patients with an active or established sun tan;
  2. Patients with history of allergic reaction to to topical anesthesia;
  3. Patients with history of keloid scarring, abnormal wound healing and/or prone to bruising;
  4. Skin malignant tumors or precancerous lesions;
  5. Patients with diabetes, heart disease, epilepsy, connective tissue disease, etc.;
  6. Pregnant or breastfeeding patients;
  7. Patients with recent skin infections (such as viral and bacterial infections);
  8. Patients who are using other methods to treat similar diseases;
  9. Patients who had taken isotretinoin within the past year;
  10. History of cryoglobulinaemia;
  11. History of cold agglutinin disease and cold haemolysis;
  12. History of cold urticaria;
  13. Parts of the body with impaired circulation;
  14. Raynaud's disease;
  15. Parts of the body with impaired sensitivity;
  16. Trophic disorders;
  17. Hypersensitivity to cold;
  18. Patients with mental illness;
  19. Other ineligible patients.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Control group: CO2 fractional laser alone
No Intervention group
Description:
This group of patients is the treatment control group. During the treatment period, the cold-air cooling device Cryo 6 will be placed next to the laser equipment but not started. The air outlet position is about 3 to 7 centimeters away from the skin, and it will move slowly and synchronously according to the laser position. The skin temperature will be synchronously monitored and recorded by hand-held infrared thermometry. After the operation, the investigators use hospital's routine aftercare procedures, and continue to use hand-held infrared thermometry to synchronously monitor the skin temperature.
Combination group: CO2 fractional laser combined with Cryo 6
Experimental group
Description:
During the CO2 fractional laser treatment, cool the skin with cold-air cooling device Cryo 6. Set the wind to level 5, and the maximum time to 30 minutes. The air outlet position is about 3 to 7 centimeters away from the skin, and it will move slowly and synchronously according to the laser position. The skin temperature will be synchronously monitored by hand-held infrared thermometry and maintained at 0°C to 5°C. After the operation, the investigators use hospital's routine aftercare procedures and cooling with Cryo 6 on the skin synchronously. The wind level can be selected by patients themselves from level 3 to 7, and the time can be set for 5 minutes. Put the air outlet about 3 to 7 centimeters away from the skin, and move it slowly and dynamically in this area of skin to monitor and record the skin temperature synchronously.
Treatment:
Device: Cold-air cooling

Trial contacts and locations

1

Loading...

Central trial contact

Kai-Yang Lv, MD-PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems